Physiological aspects of the renin-angiotensin system and peroral angiotensin converting enzyme inhibition.
D000804:Angiotensin II / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001477:Bartter Syndrome / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D008970:Molecular Weight; D007703:Peptidyl-Dipeptidase A / Q000032:analysis; D012079:Renal Circulation / Q000187:drug effects; D012083:Renin / Q000096:biosynthesis; D012084:Renin-Angiotensin System; D013564:Sympathetic Nervous System / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A; D012083:Renin